carbon monoxide has been researched along with Cardiovascular Diseases in 168 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Excerpt | Relevance | Reference |
---|---|---|
"Endogenous carbon monoxide (CO) at physiological concentrations is cytoprotective, whereas excess levels reflect underlying oxidative stress, inflammation, and vascular pathology and portend adverse clinical sequelae." | 7.76 | Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community. ( Cheng, S; Keaney, JF; Lyass, A; Massaro, JM; O'Connor, GT; Vasan, RS, 2010) |
"The study investigated long-term effects of carbon monoxide (CO) exposure on foundry workers' morbidity and mortality from cardiovascular diseases." | 7.69 | Cardiovascular diseases among foundry workers exposed to carbon monoxide. ( Koskela, RS, 1994) |
" In this review we consider of some substances which content vary in cardiovascular diseases - pentane, isoprene, carbon monoxide and trimethylamine." | 5.01 | [Exhaled Breath Analysis in Diagnostics of Cardiovascular Diseases]. ( Belyakov, VV; Betelin, VB; Bykova, AA; Chomakhidze, PS; Golovin, AV; Kopylov, PY; Malinovskaya, LK; Pershenkov, VS; Shaltaeva, YR; Syrkin, AL; Trushina, OV, 2019) |
"This review focuses on the (vaso)relaxant capacity of ruthenium-based NO-donating and CO-donating molecules in view of their potential usefulness in the treatment of cardiovascular diseases and erectile dysfunction." | 4.93 | Ruthenium-based nitric oxide-donating and carbon monoxide-donating molecules. ( Boydens, C; Pauwels, B; Van de Voorde, J; Vanden Daele, L, 2016) |
" This review examines the current literature related to: (1) smoking, lipoproteins, and lipid-related enzymes; (2) the impact of nicotine, carbon monoxide and free radicals on physiologic parameters related to health; and (3) metabolic issues involving smoking cessation and nicotine replacement therapy." | 4.84 | Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review. ( Chelland Campbell, S; Moffatt, RJ; Stamford, BA, 2008) |
" With regard to other pollutants, carbon monoxide, by chronic hypoxia, has been incriminated in destabilisation of high risk patients--coronary or cardiac insufficiency." | 4.79 | [Urban air pollution and cardiovascular disease]. ( Juliard, JM, 1997) |
"Until now, the epidemiological evidence on the association between short-term exposure to ambient carbon monoxide (CO) and cardiovascular diseases (CVDs) is relatively lacking and controversial." | 4.31 | Ambient carbon monoxide and the risk of cardiovascular disease emergency room visits: a time-series study in Lanzhou, China. ( Bao, H; Dong, J; Liu, Y; Wang, J; You, J, 2023) |
"Using a time-stratified case-crossover design, over 400,000 myocardial infarction (MI) events from the Myocardial Ischaemia National Audit Project (MINAP) database, over 2 million CVD emergency hospital admissions and over 600,000 CVD deaths were linked with daily mean concentrations of carbon monoxide (CO), nitrogen dioxide (NO2), particulate matter less than 10 μm in aerodynamic diameter (PM10), particulate matter less than 2." | 3.80 | Short-term effects of air pollution on a range of cardiovascular events in England and Wales: case-crossover analysis of the MINAP database, hospital admissions and mortality. ( Armstrong, B; Bhaskaran, K; Hajat, S; Milojevic, A; Smeeth, L; Wilkinson, P, 2014) |
"Carbon monoxide (CO) is suspected of playing a major role in cigarette smoke-induced cardiovascular diseases." | 3.76 | Acute effects of passive smoking on blood pressure and heart rate in healthy females. ( Akpek, M; Ardic, I; Calapkorur, B; Dogan, A; Dogdu, O; Kalay, N; Kaya, MG; Oguzhan, A; Ozdogru, I; Ozdogru, M; Yarlioglues, M, 2010) |
"Endogenous carbon monoxide (CO) at physiological concentrations is cytoprotective, whereas excess levels reflect underlying oxidative stress, inflammation, and vascular pathology and portend adverse clinical sequelae." | 3.76 | Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community. ( Cheng, S; Keaney, JF; Lyass, A; Massaro, JM; O'Connor, GT; Vasan, RS, 2010) |
" Daily emergency admissions for all cardiovascular diseases (CVD) and heart diseases (HD) were obtained from hospital records, and the corresponding daily levels of particulates, SO2, NO2, CO, and ozone were recorded." | 3.73 | Air pollution and cardiovascular admissions association in Spain: results within the EMECAS project. ( Arribas, F; Ballester, F; Bellido, J; Cañada, A; Cirarda, FB; Daponte, A; Galán, I; Guillén, JJ; Guillén-Grima, F; Iñíguez, C; Lertxundi, A; López, E; Pérez-Hoyos, S; Rodríguez, P; Saez, M; Taracido, M; Toro, S, 2006) |
" Rarer and thus less known are work related noxious substances (mainly nitroglycols, carbon sulfur, carbon monoxide) that lead to or at least accelerate cardiovascular diseases." | 3.69 | [Smoking in the workplace]. ( Rüegger, M, 1994) |
" The mortality from 3 hypertension-related diseases combined (cerebrovascular, hypertensive, and renal diseases) showed identical positive mortality trends among the ferrosilicon/silicon-metal (FeSi/Si-met) and the FeMn/SiMn furnace workers by increasing duration of work." | 3.69 | Mortality from cardiovascular diseases and sudden death in ferroalloy plants. ( Hobbesland, A; Kjuus, H; Thelle, DS, 1997) |
"Although many diseases, including cancer, hematological diseases, hypertension, heart failure, inflammation, sepsis, neurodegeneration, and sleep disorders, have been linked to abnormal endogenous CO metabolism and functions, CO administration has therapeutic potential in inflammation, sepsis, lung injury, cardiovascular diseases, transplantation, and cancer." | 2.48 | Carbon monoxide: an unusual drug. ( Ascenzi, P; di Masi, A; Gullotta, F, 2012) |
" Nitrates that have been used for over a century and nebivolol, a third-generation b-blocker with vasodilating properties by increasing bioavailability of NO, provide convincing arguments that the compounds acting via NO pathway will remain an important class of cardiovascular drugs." | 2.46 | [The role of nitric oxide, hydrogen sulfide and carbon monoxide in the regulation of the circulatory system and their pharmacotherapeutic potential]. ( Ufnal, M; Żera, T, 2010) |
"Patients recovering from coronavirus disease 2019 (COVID-19) may not return to a pre-COVID functional status and baseline levels of healthcare needs after discharge from acute care hospitals." | 1.62 | Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients. ( Ambrosino, P; Cazzola, M; Fuschillo, S; Maniscalco, M; Martucci, M; Matera, MG; Papa, A, 2021) |
"Ozone was not found to be significantly associated with respiratory morbidity." | 1.42 | Multifactorial airborne exposures and respiratory hospital admissions--the example of Santiago de Chile. ( Franck, U; Leitte, AM; Suppan, P, 2015) |
"Drugs found were primarily for treating obesity-related medical conditions such as depression, hypertension, and coronary heart disease." | 1.38 | Toxicological findings in 889 fatally injured obese pilots involved in aviation accidents. ( Botch, SR; Chaturvedi, AK; Ricaurte, EM, 2012) |
"Patients with obstructive sleep apnea (OSA) have an increased risk of cardiovascular morbidity." | 1.35 | Circulating carbon monoxide level is elevated after sleep in patients with obstructive sleep apnea. ( Ishigatsubo, Y; Kaneko, T; Kirino, Y; Kobayashi, M; Miyazawa, N; Murakami, S; Okouchi, A; Takeno, M, 2008) |
"Carbon monoxide was associated with both all respiratory ER visits and visits for asthma at the 3-day lag." | 1.33 | Association between particulate matter and emergency room visits, hospital admissions and mortality in Spokane, Washington. ( Claiborn, C; Kim, E; Larson, TV; Sheppard, L; Slaughter, JC; Sullivan, JH, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 36 (21.43) | 18.7374 |
1990's | 15 (8.93) | 18.2507 |
2000's | 45 (26.79) | 29.6817 |
2010's | 61 (36.31) | 24.3611 |
2020's | 11 (6.55) | 2.80 |
Authors | Studies |
---|---|
Sathish, T | 1 |
Teo, KK | 1 |
Britz-McKibbin, P | 1 |
Gill, B | 1 |
Islam, S | 1 |
Paré, G | 1 |
Rangarajan, S | 1 |
Duong, M | 1 |
Lanas, F | 1 |
Lopez-Jaramillo, P | 1 |
Mony, PK | 1 |
Pinnaka, L | 1 |
Kutty, VR | 1 |
Orlandini, A | 1 |
Avezum, A | 1 |
Wielgosz, A | 1 |
Poirier, P | 1 |
Alhabib, KF | 1 |
Temizhan, A | 1 |
Chifamba, J | 1 |
Yeates, K | 1 |
Kruger, IM | 1 |
Khatib, R | 1 |
Yusuf, R | 1 |
Rosengren, A | 1 |
Zatonska, K | 1 |
Iqbal, R | 1 |
Lui, W | 1 |
Lang, X | 1 |
Li, S | 1 |
Hu, B | 1 |
Dans, AL | 1 |
Yusufali, AH | 1 |
Bahonar, A | 1 |
O'Donnell, MJ | 1 |
McKee, M | 1 |
Yusuf, S | 1 |
Allagbé, I | 1 |
Zeller, M | 2 |
Thomas, D | 1 |
Airagnes, G | 1 |
Limosin, F | 1 |
Boussadi, A | 1 |
Chagué, F | 1 |
Le Faou, AL | 1 |
Gaalema, DE | 1 |
Collaro, AJ | 1 |
Chang, AB | 1 |
Marchant, JM | 1 |
Chatfield, MD | 1 |
Dent, A | 1 |
Fong, KM | 1 |
McElrea, MS | 1 |
Ma, JS | 1 |
Chen, J | 2 |
Huang, H | 1 |
You, J | 1 |
Liu, Y | 1 |
Dong, J | 1 |
Wang, J | 1 |
Bao, H | 1 |
Teoh, JP | 1 |
Li, X | 2 |
Simoncini, T | 1 |
Zhu, D | 1 |
Fu, X | 1 |
Qiu, G | 1 |
Yu, K | 1 |
Yu, C | 1 |
Li, W | 3 |
Lv, J | 2 |
Guo, Y | 2 |
Bian, Z | 1 |
Yang, L | 1 |
Chen, Y | 2 |
Chen, Z | 1 |
Hu, FB | 1 |
Li, L | 1 |
Wu, T | 2 |
Wang, Y | 2 |
Li, J | 1 |
Wang, L | 1 |
Lin, Y | 3 |
Zhou, M | 2 |
Yin, P | 2 |
Yao, S | 1 |
Maniscalco, M | 1 |
Fuschillo, S | 1 |
Ambrosino, P | 1 |
Martucci, M | 1 |
Papa, A | 1 |
Matera, MG | 1 |
Cazzola, M | 1 |
Choi, W | 1 |
Kim, KY | 1 |
Ha, S | 1 |
Männistö, T | 1 |
Liu, D | 1 |
Sherman, S | 1 |
Ying, Q | 1 |
Mendola, P | 1 |
Costa, AF | 1 |
Hoek, G | 1 |
Brunekreef, B | 1 |
Ponce de Leon, ACM | 1 |
Yang, BY | 1 |
Qian, Z | 1 |
Howard, SW | 1 |
Vaughn, MG | 1 |
Fan, SJ | 1 |
Liu, KK | 1 |
Dong, GH | 1 |
Dastoorpoor, M | 1 |
Goudarzi, G | 1 |
Khanjani, N | 1 |
Idani, E | 1 |
Aghababaeian, H | 1 |
Bahrampour, A | 1 |
Rezk-Hanna, M | 1 |
Benowitz, NL | 1 |
Cao, Y | 2 |
Li, R | 2 |
Ma, X | 1 |
Wu, Z | 3 |
Xu, Q | 4 |
Pan, LL | 1 |
Liu, XH | 1 |
Zhu, YZ | 1 |
Liu, HM | 1 |
Xie, L | 1 |
Maji, S | 1 |
Ghosh, S | 2 |
Ahmed, S | 1 |
Rodríguez-Villamizar, LA | 1 |
Rojas-Roa, NY | 1 |
Blanco-Becerra, LC | 1 |
Herrera-Galindo, VM | 1 |
Fernández-Niño, JA | 1 |
Kim, HH | 1 |
Choi, S | 1 |
Zheng, M | 1 |
Shi, T | 1 |
Liu, P | 1 |
Wu, Y | 1 |
Feng, W | 1 |
He, W | 1 |
Guo, P | 1 |
Yap, J | 1 |
Ng, Y | 1 |
Yeo, KK | 1 |
Sahlén, A | 1 |
Lam, CSP | 1 |
Lee, V | 1 |
Ma, S | 1 |
Yao, C | 1 |
Xu, C | 1 |
Zeng, X | 1 |
Zhang, P | 1 |
Bykova, AA | 1 |
Malinovskaya, LK | 1 |
Chomakhidze, PS | 1 |
Trushina, OV | 1 |
Shaltaeva, YR | 1 |
Belyakov, VV | 1 |
Golovin, AV | 1 |
Pershenkov, VS | 1 |
Syrkin, AL | 1 |
Betelin, VB | 1 |
Kopylov, PY | 1 |
Gingo, MR | 1 |
He, J | 1 |
Wittman, C | 1 |
Fuhrman, C | 1 |
Leader, JK | 1 |
Kessinger, C | 1 |
Lucht, L | 1 |
Slivka, WA | 1 |
Zhang, Y | 4 |
McMahon, DK | 1 |
Sciurba, FC | 1 |
Morris, A | 1 |
Foresti, R | 1 |
Motterlini, R | 3 |
Kawut, SM | 1 |
Bamonti, F | 1 |
Pellegatta, M | 1 |
Novembrino, C | 1 |
Vigna, L | 1 |
De Giuseppe, R | 1 |
de Liso, F | 1 |
Gregori, D | 1 |
Noce, CD | 1 |
Patrini, L | 1 |
Schiraldi, G | 1 |
Bonara, P | 1 |
Calvelli, L | 1 |
Maiavacca, R | 1 |
Cighetti, G | 1 |
Franck, U | 2 |
Leitte, AM | 2 |
Suppan, P | 2 |
Giles, LV | 1 |
Koehle, MS | 1 |
Yang, Y | 2 |
Wang, M | 1 |
Lavigne, E | 1 |
Gasparrini, A | 1 |
Wang, X | 1 |
Chen, H | 1 |
Yagouti, A | 1 |
Fleury, MD | 1 |
Cakmak, S | 1 |
Polhemus, DJ | 1 |
Lefer, DJ | 1 |
Cheng, S | 2 |
Enserro, D | 1 |
Xanthakis, V | 1 |
Sullivan, LM | 1 |
Murabito, JM | 1 |
Benjamin, EJ | 1 |
Polak, JF | 1 |
O'Donnell, CJ | 1 |
Wolf, PA | 1 |
O'Connor, GT | 2 |
Keaney, JF | 2 |
Vasan, RS | 2 |
Milojevic, A | 1 |
Wilkinson, P | 1 |
Armstrong, B | 1 |
Bhaskaran, K | 1 |
Smeeth, L | 1 |
Hajat, S | 1 |
Mauderly, JL | 1 |
Kracko, D | 1 |
Brower, J | 1 |
Doyle-Eisele, M | 1 |
McDonald, JD | 1 |
Lund, AK | 1 |
Seilkop, SK | 1 |
Song, Y | 1 |
Hou, J | 1 |
Huang, X | 2 |
Zhang, X | 1 |
Tan, A | 1 |
Rong, Y | 1 |
Sun, H | 1 |
Zhou, Y | 1 |
Cui, X | 1 |
Zhang, Z | 1 |
Luo, X | 1 |
Zhang, B | 1 |
Hou, F | 1 |
He, X | 1 |
Xie, J | 1 |
Chen, W | 1 |
Yuan, J | 1 |
Chang, CC | 1 |
Chen, PS | 1 |
Yang, CY | 4 |
Nordskog, BK | 1 |
Brown, BG | 1 |
Marano, KM | 1 |
Campell, LR | 1 |
Jones, BA | 1 |
Borgerding, MF | 1 |
Bérard, E | 1 |
Bongard, V | 1 |
Dallongeville, J | 1 |
Arveiler, D | 1 |
Amouyel, P | 1 |
Wagner, A | 1 |
Cottel, D | 1 |
Haas, B | 1 |
Ferrières, J | 1 |
Ruidavets, JB | 1 |
Pauwels, B | 1 |
Boydens, C | 1 |
Vanden Daele, L | 1 |
Van de Voorde, J | 1 |
Samoli, E | 2 |
Atkinson, RW | 1 |
Analitis, A | 1 |
Fuller, GW | 1 |
Green, DC | 1 |
Mudway, I | 1 |
Anderson, HR | 2 |
Kelly, FJ | 1 |
Brath, H | 1 |
Grabovac, I | 1 |
Schalk, H | 1 |
Degen, O | 1 |
Dorner, TE | 1 |
Requia, WJ | 1 |
Koutrakis, P | 1 |
Roig, HL | 1 |
Adams, MD | 1 |
Santos, CM | 1 |
Almendra, R | 1 |
Santana, P | 1 |
Vasconcelos, J | 1 |
Silva, G | 1 |
Gonçalves, F | 1 |
Ambrizzi, T | 1 |
Ayer, A | 1 |
Zarjou, A | 1 |
Agarwal, A | 2 |
Stocker, R | 1 |
Tzeng, E | 1 |
Chelland Campbell, S | 1 |
Moffatt, RJ | 1 |
Stamford, BA | 1 |
Loboda, A | 1 |
Jazwa, A | 1 |
Grochot-Przeczek, A | 1 |
Rutkowski, AJ | 1 |
Cisowski, J | 1 |
Jozkowicz, A | 1 |
Dulak, J | 1 |
Idriss, NK | 1 |
Blann, AD | 1 |
Lip, GY | 1 |
Kobayashi, M | 1 |
Miyazawa, N | 1 |
Takeno, M | 1 |
Murakami, S | 1 |
Kirino, Y | 1 |
Okouchi, A | 1 |
Kaneko, T | 1 |
Ishigatsubo, Y | 1 |
Bazer, FW | 1 |
Gao, H | 1 |
Jobgen, W | 1 |
Johnson, GA | 1 |
Li, P | 1 |
McKnight, JR | 1 |
Satterfield, MC | 1 |
Spencer, TE | 1 |
Wu, G | 1 |
Janke, K | 1 |
Propper, C | 1 |
Henderson, J | 1 |
Sanhueza, P | 1 |
Pizarro, J | 1 |
Vargas, C | 1 |
Torreblanca, M | 1 |
Passalacqua, M | 1 |
Peters, A | 2 |
Bell, ML | 1 |
Peng, RD | 1 |
Dominici, F | 2 |
Samet, JM | 2 |
Gal, J | 1 |
Marczin, N | 1 |
Lin, CM | 1 |
Liao, CM | 1 |
Peel, JL | 2 |
Klein, M | 3 |
Flanders, WD | 2 |
Mulholland, JA | 2 |
Tolbert, PE | 2 |
Yarlioglues, M | 1 |
Kaya, MG | 1 |
Ardic, I | 1 |
Calapkorur, B | 1 |
Dogdu, O | 1 |
Akpek, M | 1 |
Ozdogru, M | 1 |
Kalay, N | 1 |
Dogan, A | 1 |
Ozdogru, I | 1 |
Oguzhan, A | 1 |
Otterbein, LE | 1 |
Brunelli, A | 1 |
Lyass, A | 1 |
Massaro, JM | 1 |
Chen, R | 2 |
Pan, G | 2 |
Kan, H | 2 |
Tan, J | 1 |
Song, W | 1 |
Xu, X | 2 |
Jiang, C | 1 |
Chen, B | 2 |
Kim, YM | 1 |
Kim, JW | 1 |
Lee, HJ | 1 |
Ito, K | 1 |
Mathes, R | 1 |
Ross, Z | 1 |
Nádas, A | 1 |
Thurston, G | 1 |
Matte, T | 1 |
Budinger, GR | 1 |
Mutlu, GM | 1 |
Zeng, G | 1 |
Tao, Y | 1 |
Zhong, L | 1 |
Lu, SE | 2 |
Li, Y | 1 |
Dai, L | 1 |
Zhu, T | 2 |
Huang, W | 2 |
Wichmann, J | 1 |
Andersen, ZJ | 1 |
Ketzel, M | 1 |
Ellermann, T | 1 |
Loft, S | 1 |
Leone, A | 1 |
Landini, L | 1 |
Ufnal, M | 1 |
Żera, T | 1 |
Chaturvedi, AK | 1 |
Botch, SR | 1 |
Ricaurte, EM | 1 |
Romão, CC | 1 |
Blättler, WA | 1 |
Seixas, JD | 1 |
Bernardes, GJ | 1 |
Gullotta, F | 1 |
di Masi, A | 1 |
Ascenzi, P | 1 |
Pan, X | 1 |
Hu, M | 1 |
Wang, T | 1 |
Tang, X | 1 |
Winquist, A | 1 |
Tolbert, P | 1 |
Sarnat, SE | 1 |
Rochette, L | 1 |
Cottin, Y | 1 |
Vergely, C | 1 |
Haustein, KO | 2 |
Krause, J | 2 |
Haustein, H | 2 |
Rasmussen, T | 2 |
Cort, N | 2 |
Shibahara, S | 1 |
Kitamuro, T | 1 |
Takahashi, K | 1 |
Kwon, HJ | 1 |
Cho, SH | 1 |
Chun, Y | 1 |
Lagarde, F | 1 |
Pershagen, G | 1 |
Vedal, S | 1 |
Brauer, M | 1 |
White, R | 1 |
Petkau, J | 1 |
Götz, R | 1 |
Palda, VA | 1 |
Tsai, SS | 1 |
Huang, CH | 1 |
Goggins, WB | 1 |
Wu, TN | 1 |
McGrath, JJ | 1 |
TAMASKA, L | 1 |
SOLYMOSI, M | 1 |
WAKERLIN, G | 1 |
Holguín, F | 1 |
Téllez-Rojo, MM | 1 |
Hernández, M | 1 |
Cortez, M | 1 |
Chow, JC | 1 |
Watson, JG | 1 |
Mannino, D | 1 |
Romieu, I | 1 |
Chen, YS | 2 |
Yang, CH | 1 |
Ho, SC | 1 |
Bełtowski, J | 1 |
Jamroz, A | 1 |
Borkowska, E | 1 |
Chatterjee, PK | 1 |
Brook, RD | 1 |
Franklin, B | 1 |
Cascio, W | 1 |
Hong, Y | 1 |
Howard, G | 1 |
Lipsett, M | 1 |
Luepker, R | 1 |
Mittleman, M | 1 |
Samet, J | 1 |
Smith, SC | 1 |
Tager, I | 1 |
Slaughter, JC | 1 |
Kim, E | 1 |
Sheppard, L | 1 |
Sullivan, JH | 1 |
Larson, TV | 1 |
Claiborn, C | 1 |
Liao, D | 1 |
Heiss, G | 1 |
Chinchilli, VM | 1 |
Duan, Y | 1 |
Folsom, AR | 1 |
Lin, HM | 1 |
Salomaa, V | 1 |
Abraham, NG | 1 |
Kappas, A | 1 |
Jin, HF | 1 |
Du, JB | 1 |
Tang, CS | 1 |
Rainham, DG | 1 |
Smoyer-Tomic, KE | 1 |
Sheridan, SC | 1 |
Burnett, RT | 1 |
Scharte, M | 1 |
von Ostrowski, TA | 1 |
Daudel, F | 1 |
Freise, H | 1 |
Van Aken, H | 1 |
Bone, HG | 1 |
Hinwood, AL | 1 |
De Klerk, N | 1 |
Rodriguez, C | 1 |
Jacoby, P | 1 |
Runnion, T | 1 |
Rye, P | 1 |
Landau, L | 1 |
Murray, F | 1 |
Feldwick, M | 1 |
Spickett, J | 1 |
Immenschuh, S | 1 |
Schröder, H | 1 |
Ballester, F | 2 |
Rodríguez, P | 1 |
Iñíguez, C | 1 |
Saez, M | 1 |
Daponte, A | 1 |
Galán, I | 1 |
Taracido, M | 1 |
Arribas, F | 1 |
Bellido, J | 1 |
Cirarda, FB | 1 |
Cañada, A | 1 |
Guillén, JJ | 1 |
Guillén-Grima, F | 1 |
López, E | 1 |
Pérez-Hoyos, S | 2 |
Lertxundi, A | 1 |
Toro, S | 1 |
Vannacci, A | 1 |
Marzocca, C | 1 |
Giannini, L | 1 |
Mazzetti, L | 1 |
Franchi-Micheli, S | 1 |
Failli, P | 1 |
Masini, E | 1 |
Mannaioni, PF | 1 |
Hedblad, B | 1 |
Engström, G | 1 |
Janzon, E | 1 |
Berglund, G | 1 |
Janzon, L | 1 |
Metzger, KB | 1 |
Cançado, JE | 1 |
Braga, A | 1 |
Pereira, LA | 1 |
Arbex, MA | 1 |
Saldiva, PH | 1 |
Santos, Ude P | 1 |
Halvorsen, B | 1 |
Lund Sagen, E | 1 |
Ueland, T | 1 |
Aukrust, P | 1 |
Tonstad, S | 1 |
Touloumi, G | 1 |
Schwartz, J | 2 |
Schindler, C | 1 |
Forsberg, B | 1 |
Vigotti, MA | 1 |
Vonk, J | 1 |
Kosnik, M | 1 |
Skorkovsky, J | 1 |
Katsouyanni, K | 1 |
Bledsoe, BE | 1 |
Nautiyal, J | 1 |
Garg, ML | 1 |
Kumar, MS | 1 |
Khan, AA | 1 |
Thakur, JS | 1 |
Kumar, R | 1 |
Mulhausen, R | 1 |
Astrup, P | 3 |
Kjeldsen, K | 3 |
del Piano, M | 1 |
La Palombara, P | 1 |
Nicosia, R | 1 |
Sessa, R | 1 |
Ganguin, HG | 1 |
Wilde, J | 1 |
Horvath, SM | 1 |
Lefcoe, NM | 1 |
Ashley, MJ | 1 |
Pederson, LL | 1 |
Keays, JJ | 1 |
Aronow, WS | 4 |
Kuller, LH | 1 |
Radford, EP | 1 |
Cambien, F | 1 |
Richard, JL | 1 |
Ducimetiere, P | 1 |
Warnet, JM | 1 |
Kahn, J | 1 |
Rozenberg, S | 1 |
González, ER | 1 |
Harlan, WR | 1 |
Sharrett, AR | 1 |
Weill, H | 1 |
Turino, GM | 1 |
Borhani, NO | 1 |
Resnekov, L | 1 |
Koskela, RS | 1 |
Rüegger, M | 1 |
Mennear, JH | 1 |
Steimle, S | 1 |
Kales, SN | 1 |
Hausberg, M | 1 |
Somers, VK | 1 |
Döring, A | 1 |
Wichmann, HE | 2 |
Koenig, W | 1 |
Bünger, J | 1 |
Bombosch, F | 1 |
Mesecke, U | 1 |
Hallier, E | 1 |
Hobbesland, A | 1 |
Kjuus, H | 1 |
Thelle, DS | 1 |
Juliard, JM | 1 |
Yang, W | 1 |
Jennison, BL | 1 |
Omaye, ST | 1 |
Tritto, I | 1 |
Ambrosio, G | 1 |
Linn, WS | 1 |
Szlachcic, Y | 1 |
Gong, H | 1 |
Kinney, PL | 1 |
Berhane, KT | 1 |
Tenías, JM | 1 |
Curriero, FC | 1 |
Coursac, I | 1 |
Zeger, SL | 1 |
Michelozzi, P | 1 |
Forastiere, F | 1 |
Perucci, CA | 1 |
Fusco, D | 1 |
Barca, A | 1 |
Spadea, T | 1 |
Charter, R | 1 |
Seacat, G | 1 |
Carratu', L | 1 |
Marangio, E | 1 |
Pesci, A | 1 |
Rosenman, KD | 1 |
Schievelbein, H | 2 |
Gori, GB | 1 |
Dawber, TR | 1 |
Thomas, HE | 1 |
Schmeltz, I | 1 |
Hoffmann, D | 1 |
Wynder, EL | 1 |
Cooke, TF | 1 |
Mueller, W | 1 |
Allhoff, P | 1 |
Beckmann, M | 1 |
Bocter, N | 1 |
Csicsaky, MJ | 1 |
Jung, M | 1 |
Molik, B | 1 |
Schoeneberg, G | 1 |
Sallis, JF | 1 |
Haskell, WL | 1 |
Wood, PD | 1 |
Fortmann, SP | 1 |
Vranizan, KM | 1 |
Schlapman, N | 1 |
Pasqualucci, CA | 1 |
Bloch, WN | 1 |
Lewis, TR | 1 |
Busch, KA | 1 |
Orthoefer, JG | 1 |
Stara, JF | 1 |
Abelin, T | 1 |
Nikberg, II | 1 |
Murashko, VA | 1 |
Leonenko, IN | 1 |
Eberhardt, R | 1 |
Davies, DM | 1 |
Goldsmith, JR | 1 |
Katzschmann, R | 1 |
Wanstrup, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Reducing AIR Pollution Exposure to Lower Blood PRESSURE[NCT04908917] | 200 participants (Anticipated) | Interventional | 2021-07-01 | Not yet recruiting | |||
Adiposity and Airway Inflammation in HIV-Associated Airway Disease[NCT02975258] | 102 participants (Actual) | Observational | 2015-09-30 | Completed | |||
Evaluation of Cardiovascular Disease Biomarkers in Exclusive Smokers and Exclusive Moist Snuff Consumers[NCT01692353] | 168 participants (Actual) | Observational | 2008-09-30 | Completed | |||
Improving the Behavioural Impact of Air Quality Alerts in London[NCT03552198] | 225 participants (Actual) | Interventional | 2017-07-23 | Completed | |||
The Association of Cigarette Smoking on Exercise Capacity and Skeletal Muscle Function in Taiwan Adult Smokers[NCT04688177] | 52 participants (Actual) | Observational | 2020-12-03 | Completed | |||
Pulmonary Abnormalities, Diastolic Dysfunction, and World Trade Center Exposure: Implications for Diagnosis and Treatment[NCT01466218] | 1,012 participants (Actual) | Observational | 2011-11-30 | Completed | |||
Measuring Knowledge and Behavior After an Educational Program on Air Pollution as a Health Risk Reduction Strategy[NCT04563052] | 40 participants (Actual) | Interventional | 2020-01-28 | Completed | |||
The Effectiveness of Rhinopharyngeal Retrograde Clearance on the Upper Airways Symptomatology and Function in Adults[NCT01976039] | 24 participants (Actual) | Interventional | 2012-07-31 | Completed | |||
A Phase Ib Trial of Inhaled Carbon Monoxide for the Treatment of Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)[NCT04870125] | Phase 1 | 36 participants (Anticipated) | Interventional | 2023-12-06 | Recruiting | ||
A Phase II Trial of Inhaled Carbon Monoxide for the Treatment of Acute Respiratory Distress Syndrome (ARDS)[NCT03799874] | Phase 2 | 32 participants (Anticipated) | Interventional | 2019-07-01 | Active, not recruiting | ||
[NCT00005143] | 2,504 participants (Actual) | Observational | 1978-07-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Differences between conditions in actual adoption of protective behaviours at 4 weeks. Outcome measures were collected via self-reports: The question was: 'In the past 4 weeks, how often have you taken action to reduce exposure to air pollution, in response to hearing or reading an air quality forecast?' Measures: from 1 'Not at all' to 9 'all of the time' (answers 'N/A, I am not aware of any forecast' were excluded from analyses). (NCT03552198)
Timeframe: Baseline and at 4 weeks
Intervention | units on a scale 1-9 (Mean) |
---|---|
General Public/Usual Health Advice | 3.67 |
General Public/Alternative Health Advice | 4.25 |
At Risk Group/Usual Health Advice | 4.29 |
At Risk Group/Alternative Health Advice | 3.65 |
Differences between conditions in intentions to adhere to the health advice received in association with a hypothetical high air pollution alert scenario. Intentions were measured by a self-report item: participants were asked to agree with a statement about their adherence intentions on 9-point scale, where 1=strongly disagree to 9=strongly agree. (NCT03552198)
Timeframe: Baseline and at 4 weeks
Intervention | score on a scale (Mean) |
---|---|
General Public/Usual Health Advice | 6.69 |
General Public/Alternative Health Advice | 6.26 |
At Risk Group/Usual Health Advice | 7.58 |
At Risk Group/Alternative Health Advice | 6.93 |
Differences between conditions in self-reported actual behaviour change in response to receiving a real air quality alert. Behavioural outcomes were collected via a questionnaire asking participants to respond 'yes/no' to whether they had changed a series of behaviours in response to receiving the alert. In this case it was a 'moderate' alert (NCT03552198)
Timeframe: At 3 weeks
Intervention | Participants (Count of Participants) | |||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Changed level/length of physical activity outdoors72495079 | Changed level/length of physical activity outdoors72495080 | Changed level/length of physical activity outdoors72495081 | Changed level/length of physical activity outdoors72495082 | Changed travel route72495079 | Changed travel route72495080 | Changed travel route72495081 | Changed travel route72495082 | Changed travel time72495080 | Changed travel time72495081 | Changed travel time72495082 | Changed travel time72495079 | Changed exercise time72495079 | Changed exercise time72495080 | Changed exercise time72495082 | Changed exercise time72495081 | Changed exercise location72495080 | Changed exercise location72495082 | Changed exercise location72495079 | Changed exercise location72495081 | |||||||||||||||||||||
Yes | No | |||||||||||||||||||||||||||||||||||||||
General Public/Usual Health Advice | 3 | |||||||||||||||||||||||||||||||||||||||
General Public/Alternative Health Advice | 2 | |||||||||||||||||||||||||||||||||||||||
At Risk Group/Usual Health Advice | 2 | |||||||||||||||||||||||||||||||||||||||
At Risk Group/Alternative Health Advice | 5 | |||||||||||||||||||||||||||||||||||||||
General Public/Alternative Health Advice | 23 | |||||||||||||||||||||||||||||||||||||||
At Risk Group/Usual Health Advice | 4 | |||||||||||||||||||||||||||||||||||||||
At Risk Group/Alternative Health Advice | 7 | |||||||||||||||||||||||||||||||||||||||
General Public/Usual Health Advice | 4 | |||||||||||||||||||||||||||||||||||||||
At Risk Group/Usual Health Advice | 1 | |||||||||||||||||||||||||||||||||||||||
At Risk Group/Alternative Health Advice | 4 | |||||||||||||||||||||||||||||||||||||||
At Risk Group/Usual Health Advice | 6 | |||||||||||||||||||||||||||||||||||||||
General Public/Usual Health Advice | 0 | |||||||||||||||||||||||||||||||||||||||
General Public/Alternative Health Advice | 3 | |||||||||||||||||||||||||||||||||||||||
At Risk Group/Alternative Health Advice | 2 | |||||||||||||||||||||||||||||||||||||||
General Public/Usual Health Advice | 19 | |||||||||||||||||||||||||||||||||||||||
General Public/Alternative Health Advice | 22 | |||||||||||||||||||||||||||||||||||||||
At Risk Group/Alternative Health Advice | 9 | |||||||||||||||||||||||||||||||||||||||
General Public/Alternative Health Advice | 5 | |||||||||||||||||||||||||||||||||||||||
General Public/Usual Health Advice | 16 | |||||||||||||||||||||||||||||||||||||||
General Public/Alternative Health Advice | 19 | |||||||||||||||||||||||||||||||||||||||
At Risk Group/Usual Health Advice | 5 | |||||||||||||||||||||||||||||||||||||||
At Risk Group/Alternative Health Advice | 11 | |||||||||||||||||||||||||||||||||||||||
General Public/Usual Health Advice | 2 | |||||||||||||||||||||||||||||||||||||||
General Public/Alternative Health Advice | 6 | |||||||||||||||||||||||||||||||||||||||
At Risk Group/Alternative Health Advice | 1 | |||||||||||||||||||||||||||||||||||||||
General Public/Usual Health Advice | 15 | |||||||||||||||||||||||||||||||||||||||
General Public/Alternative Health Advice | 18 | |||||||||||||||||||||||||||||||||||||||
At Risk Group/Alternative Health Advice | 10 |
46 reviews available for carbon monoxide and Cardiovascular Diseases
Article | Year |
---|---|
[Role and mechanism of hydrogen sulfide in vascular calcification].
Topics: Animals; Antioxidants; Carbon Monoxide; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Mammals; | 2022 |
Estrogen-Mediated Gaseous Signaling Molecules in Cardiovascular Disease.
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Estrogens; Female; Gasotransmitters; Humans; Hydr | 2020 |
Global association between ambient air pollution and blood pressure: A systematic review and meta-analysis.
Topics: Adult; Air Pollutants; Air Pollution; Blood Pressure; Carbon Monoxide; Cardiovascular Diseases; Envi | 2018 |
Cardiovascular Effects of Hookah Smoking: Potential Implications for Cardiovascular Risk.
Topics: Carbon Monoxide; Cardiovascular Diseases; Humans; Risk Factors; Smoke; Smoking Water Pipes; Tobacco, | 2019 |
[Role Ofhydrogen Sulfide on Inflammatory Immune Disorders in Cardiovascular Diseases].
Topics: Carbon Monoxide; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Immune System Diseases; Inflamma | 2017 |
[The Regulation Effects of Carbon Monoxide in Cardiovascular Systems].
Topics: Carbon Monoxide; Cardiovascular Diseases; Cardiovascular System; Humans | 2017 |
Therapeutic Aspects of Carbon Monoxide in Cardiovascular Disease.
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Heat-Shock Proteins; Humans; Mitochondria; Reacti | 2018 |
[Exhaled Breath Analysis in Diagnostics of Cardiovascular Diseases].
Topics: Biomarkers; Breath Tests; Carbon Monoxide; Cardiovascular Diseases; Exhalation; Humans | 2019 |
The health effects of exercising in air pollution.
Topics: Air Pollution; Animals; Carbon Monoxide; Cardiovascular Diseases; Cognition Disorders; Disease Model | 2014 |
Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease.
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Gasotransmitters; Humans; Hydrogen Sulfide; Nitri | 2014 |
Ruthenium-based nitric oxide-donating and carbon monoxide-donating molecules.
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Coordination Complexes; Erectile Dysfunction; Hum | 2016 |
Heme Oxygenases in Cardiovascular Health and Disease.
Topics: Animals; Biliverdine; Carbon Monoxide; Cardiovascular Diseases; Cardiovascular System; Heme; Heme Ox | 2016 |
Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review.
Topics: Carbon Monoxide; Cardiovascular Diseases; Dose-Response Relationship, Drug; Female; Humans; Lipids; | 2008 |
Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities.
Topics: Animals; Apoptosis; Biliverdine; Carbon Monoxide; Cardiovascular Agents; Cardiovascular Diseases; Ch | 2008 |
Hemoxygenase-1 in cardiovascular disease.
Topics: Animals; Antioxidants; Bilirubin; Carbon Monoxide; Cardiovascular Diseases; Diabetes Mellitus; Heme | 2008 |
Amino acids and gaseous signaling.
Topics: Amino Acids; Animals; Carbon Monoxide; Cardiovascular Diseases; Energy Metabolism; Humans; Hydrogen | 2009 |
Carbon monoxide: endogenous mediator, potential diagnostic and therapeutic target.
Topics: Animals; Biomarkers; Carbon Monoxide; Cardiovascular Diseases; Exhalation; Gene Expression; Heme Oxy | 2010 |
The therapeutic potential of carbon monoxide.
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Homeostasis; Humans; Inflammation; Organ Transpla | 2010 |
Risk assessment for pulmonary resection.
Topics: Algorithms; Carbon Monoxide; Cardiovascular Diseases; Exercise Test; Forced Expiratory Volume; Human | 2010 |
Update in environmental and occupational medicine 2010.
Topics: Air Pollution; Asthma; Biomass; Carbon Monoxide; Cardiovascular Diseases; Humans; Lung Diseases; Occ | 2011 |
Vascular pathology from smoking: look at the microcirculation!
Topics: Animals; Atherosclerosis; Brain; Carbon Monoxide; Cardiovascular Diseases; Humans; Kidney; Microcirc | 2013 |
[The role of nitric oxide, hydrogen sulfide and carbon monoxide in the regulation of the circulatory system and their pharmacotherapeutic potential].
Topics: Carbon Monoxide; Cardiovascular Diseases; Cardiovascular System; Coronary Circulation; Humans; Hydro | 2010 |
Developing drug molecules for therapy with carbon monoxide.
Topics: Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Coordination Complexes; Humans; Liver; | 2012 |
Carbon monoxide: an unusual drug.
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Enzyme Induction; Heme Oxygenase-1; Humans; Infla | 2012 |
Carbon monoxide: mechanisms of action and potential clinical implications.
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Endothelium, Vascular; Heme; Heme Oxygenase-1; Hu | 2013 |
Heme degradation and human disease: diversity is the soul of life.
Topics: Animals; Antioxidants; Bilirubin; Carbon Monoxide; Cardiovascular Diseases; Crigler-Najjar Syndrome; | 2002 |
Is foundry work a risk for cardiovascular disease? A systematic review.
Topics: Bias; Carbon Monoxide; Cardiovascular Diseases; Female; Humans; Male; Metallurgy; Occupational Disea | 2003 |
Biological plausibility for carbon monoxide as a copollutant in PM epidemiologic studies.
Topics: Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Humans; Myocardium; Myoglobin; Oxygen; Par | 2000 |
[Heme oxygenase and carbon monoxide in the physiology and pathology of the cardiovascular system].
Topics: Apoptosis; Bilirubin; Carbon Monoxide; Cardiovascular Diseases; Heart Transplantation; Heme Oxygenas | 2004 |
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Disease Susceptibility; Epi | 2004 |
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Disease Susceptibility; Epi | 2004 |
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Disease Susceptibility; Epi | 2004 |
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Disease Susceptibility; Epi | 2004 |
Heme oxygenase and the cardiovascular-renal system.
Topics: Angioplasty, Balloon; Animals; Antioxidants; Apoptosis; Arachidonic Acid; Bilirubin; Carbon Monoxide | 2005 |
[Significance of gaseous signal molecule in the pathogenesis of cardiovascular diseases].
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Hypertension; Hypertens | 2005 |
Heme oxygenase-1 and cardiovascular disease.
Topics: Animals; Atherosclerosis; Bilirubin; Cadmium Chloride; Carbon Monoxide; Cardiovascular Diseases; Cel | 2006 |
[Clinical repercussions of exposure to atmospheric pollution].
Topics: Air Pollutants; Air Pollution; Brazil; Carbon Monoxide; Cardiovascular Diseases; Chronic Disease; En | 2006 |
[Smoking or health].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Bronchial Neoplasms; Carbon Monoxide; Cardiovascular Dise | 1980 |
Impact of air quality in exercise performance.
Topics: Adult; Air Pollution; Asbestos; Carbon Monoxide; Cardiovascular Diseases; Environmental Pollutants; | 1981 |
The health risks of passive smoking. The growing case for control measures in enclosed environments.
Topics: Adult; Carbon Monoxide; Cardiovascular Diseases; Child; Child, Preschool; Female; Humans; Legislatio | 1983 |
Carbon monoxide and cardiovascular disease.
Topics: Angina Pectoris; Arteriosclerosis; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Coro | 1983 |
Carbon monoxide and cardiovascular disease: an analysis of the weight of evidence.
Topics: Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Humans; Risk Factors; Tobacco Smoke Pol | 1993 |
Health effects of outdoor air pollution. Committee of the Environmental and Occupational Health Assembly of the American Thoracic Society.
Topics: Adult; Aerosols; Air Pollutants; Air Pollution; Animals; Asthma; Biomarkers; Bronchial Hyperreactivi | 1996 |
[Urban air pollution and cardiovascular disease].
Topics: Aged; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Cohort Studies; Europe; Female; Human | 1997 |
Spotlight on microcirculation: an update.
Topics: Aging; Animals; Carbon Monoxide; Cardiovascular Diseases; Endothelium, Vascular; Endotoxemia; Humans | 1999 |
[Smoking and the cardiovascular system].
Topics: Aged; Arteriosclerosis; Carbon Monoxide; Cardiovascular Diseases; Cardiovascular System; Coronary Di | 1978 |
The influence of tobacco smoke on indoor atmospheres.
Topics: Air Pollution; Animals; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Environment, Co | 1975 |
Indoor air pollutants. A literature review.
Topics: Air Pollution, Indoor; Asbestos; Asphyxia; Carbon Monoxide; Cardiovascular Diseases; Formaldehyde; H | 1991 |
[Effect of carbon monoxide on cardiovascular system].
Topics: Animals; Arteriosclerosis Obliterans; Carbon Monoxide; Carbon Monoxide Poisoning; Cardiovascular Dis | 1985 |
6 trials available for carbon monoxide and Cardiovascular Diseases
Article | Year |
---|---|
An encapsulated juice powder concentrate improves markers of pulmonary function and cardiovascular risk factors in heavy smokers.
Topics: Adult; Biomarkers; Capsules; Carbon Monoxide; Cardiovascular Diseases; Cysteine; Dietary Supplements | 2013 |
Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology.
Topics: Adult; Blood Cell Count; Blood Flow Velocity; Blood Viscosity; Capillaries; Carbon Monoxide; Cardiov | 2002 |
Comparison of the effects of combined nicotine replacement therapy vs. cigarette smoking in males.
Topics: Administration, Cutaneous; Adult; Blood Gas Monitoring, Transcutaneous; Carbon Monoxide; Cardiovascu | 2003 |
The Paris Cardiovascular Risk Factor Prevention Trial. Effects of two years of intervention in a population of young men.
Topics: Adult; Blood Pressure; Body Weight; Carbon Monoxide; Cardiovascular Diseases; Cholesterol; Diet; Hum | 1981 |
Neural circulatory responses to carbon monoxide in healthy humans.
Topics: Adult; Blood Pressure; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Double-Blind Met | 1997 |
Neural circulatory responses to carbon monoxide in healthy humans.
Topics: Adult; Blood Pressure; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Double-Blind Met | 1997 |
Neural circulatory responses to carbon monoxide in healthy humans.
Topics: Adult; Blood Pressure; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Double-Blind Met | 1997 |
Neural circulatory responses to carbon monoxide in healthy humans.
Topics: Adult; Blood Pressure; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Double-Blind Met | 1997 |
Effect of 4% carboxyhemoglobin on human performance in cardiac patients.
Topics: Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Clinical Trials as Topic; Double-Blind | 1979 |
116 other studies available for carbon monoxide and Cardiovascular Diseases
Article | Year |
---|---|
Variations in risks from smoking between high-income, middle-income, and low-income countries: an analysis of data from 179 000 participants from 63 countries.
Topics: Adult; Aged; Carbon Monoxide; Cardiovascular Diseases; Developed Countries; Developing Countries; Fe | 2022 |
Cardiovascular Risk Among Patients Who Smoke: Risk Profiles and Differences by Sex.
Topics: Adolescent; Adult; Carbon Monoxide; Cardiovascular Diseases; Female; Heart Disease Risk Factors; Hum | 2022 |
Carbon Monoxide and Its Effects on Those With Cardiovascular Disease.
Topics: Carbon Monoxide; Cardiovascular Diseases; Humans | 2022 |
Association of Gas Diffusing Capacity of the Lung for Carbon Monoxide with Cardiovascular Morbidity and Survival in a Disadvantaged Clinical Population.
Topics: Adult; Carbon Monoxide; Cardiovascular Diseases; Cohort Studies; Humans; Lung; Pulmonary Diffusing C | 2022 |
Ambient carbon monoxide and the risk of cardiovascular disease emergency room visits: a time-series study in Lanzhou, China.
Topics: Aged; Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; China; Emergency Serv | 2023 |
Association of exhaled carbon monoxide with risk of cardio-cerebral-vascular disease in the China Kadoorie Biobank cohort study.
Topics: Adult; Aged; Biological Specimen Banks; Carbon Monoxide; Cardiovascular Diseases; Cerebrovascular Di | 2020 |
The impact of carbon monoxide on years of life lost and modified effect by individual- and city-level characteristics: Evidence from a nationwide time-series study in China.
Topics: Aged; Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; China; Cities; Enviro | 2021 |
Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients.
Topics: Carbon Monoxide; Cardiovascular Diseases; Comorbidity; COVID-19; Female; Forced Expiratory Volume; H | 2021 |
Association between exposure level of air pollutants and incidence rate of circulatory disease in residential and industrial areas of South Korea.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Environmental Exposure; Hum | 2022 |
Air pollution and cardiovascular events at labor and delivery: a case-crossover analysis.
Topics: Adult; Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Cross-Over Studies; | 2017 |
Effects of NO
Topics: Aged; Aged, 80 and over; Air Pollutants; Brazil; Carbon Monoxide; Cardiovascular Diseases; Environme | 2017 |
Lag time structure of cardiovascular deaths attributed to ambient air pollutants in Ahvaz, Iran, 2008-2015.
Topics: Adolescent; Adult; Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Environm | 2018 |
The spatial variation in the effects of air pollution on cardiovascular mortality in Beijing, China.
Topics: Air Pollutants; Air Pollution; Beijing; Carbon Monoxide; Cardiovascular Diseases; Humans; Nitrogen D | 2018 |
Association of air quality with respiratory and cardiovascular morbidity rate in Delhi, India.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Cities; Environmental Expos | 2018 |
Short-Term Effects of Air Pollution on Respiratory and Circulatory Morbidity in Colombia 2011⁻2014: A Multi-City, Time-Series Analysis.
Topics: Adolescent; Adult; Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Child; C | 2018 |
Interactions between ambient air pollutants and temperature on emergency department visits: Analysis of varying-coefficient model in Guangzhou, China.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; China; Cities; Emergency Se | 2019 |
Particulate air pollution on cardiovascular mortality in the tropics: impact on the elderly.
Topics: Adolescent; Adult; Aged; Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Ch | 2019 |
Carbon monoxide and risk of outpatient visits due to cause-specific diseases: a time-series study in Yichang, China.
Topics: Adolescent; Adult; Aged; Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Child; Child, Pre | 2019 |
Contributors to diffusion impairment in HIV-infected persons.
Topics: Adult; Carbon Monoxide; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Echocardio | 2014 |
CO-releasing molecules: avoiding toxicity and exploiting the beneficial effects of CO for the treatment of cardiovascular disorders.
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Drug Carriers; Humans; Organometallic Compounds; | 2013 |
COPD: CardiOPulmonary Disease?
Topics: Carbon Monoxide; Cardiovascular Diseases; Humans; Phenotype; Pulmonary Disease, Chronic Obstructive; | 2013 |
Multiple exposures to airborne pollutants and hospital admissions due to diseases of the circulatory system in Santiago de Chile.
Topics: Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Chile; Cities; Environmental Exposure; Huma | 2014 |
The association between ambient air pollution and daily mortality in Beijing after the 2008 olympics: a time series study.
Topics: Adolescent; Adult; Aged; Air Pollutants; Air Pollution; Algorithms; Asian People; Carbon Monoxide; C | 2013 |
Extreme ambient temperatures and cardiorespiratory emergency room visits: assessing risk by comorbid health conditions in a time series study.
Topics: Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Comorbidity; Emergency Service, Hospital; | 2014 |
Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes.
Topics: Biomarkers; Breath Tests; Carbon Monoxide; Cardiovascular Diseases; Female; Humans; Incidence; Male; | 2014 |
Short-term effects of air pollution on a range of cardiovascular events in England and Wales: case-crossover analysis of the MINAP database, hospital admissions and mortality.
Topics: Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Atrial Fibrillation; Carbon Monoxide; Cardio | 2014 |
The National Environmental Respiratory Center (NERC) experiment in multi-pollutant air quality health research: IV. Vascular effects of repeated inhalation exposure to a mixture of five inorganic gases.
Topics: Air Pollutants; Ammonia; Animals; Apolipoproteins E; Carbon Monoxide; Cardiovascular Diseases; Dose- | 2014 |
Multifactorial airborne exposures and respiratory hospital admissions--the example of Santiago de Chile.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Chile; Environmental Exposu | 2015 |
The Wuhan-Zhuhai (WHZH) cohort study of environmental air particulate matter and the pathogenesis of cardiopulmonary diseases: study design, methods and baseline characteristics of the cohort.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Air Pollutants; Blood Pressure; Breath Tests; Carbon Mon | 2014 |
Short-term effects of fine particulate air pollution on hospital admissions for cardiovascular diseases: a case-crossover study in a tropical city.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Cities; Cross-Over Studies; | 2015 |
Study of cardiovascular disease biomarkers among tobacco consumers, part 2: biomarkers of biological effect.
Topics: Adult; Ankle Brachial Index; Biomarkers; Blood Pressure; Carbon Monoxide; Cardiovascular Diseases; C | 2015 |
Expired-air carbon monoxide as a predictor of 16-year risk of all-cause, cardiovascular and cancer mortality.
Topics: Adult; Biomarkers; Breath Tests; Carbon Monoxide; Cardiovascular Diseases; Cause of Death; Female; F | 2015 |
Associations of short-term exposure to traffic-related air pollution with cardiovascular and respiratory hospital admissions in London, UK.
Topics: Adolescent; Adult; Aged; Air Pollutants; Air Pollution; Aluminum; Carbon Monoxide; Cardiovascular Di | 2016 |
Prevalence and Correlates of Smoking and Readiness to Quit Smoking in People Living with HIV in Austria and Germany.
Topics: Adult; Age Factors; Anti-HIV Agents; Antidepressive Agents; Attitude to Health; Austria; Breath Test | 2016 |
Association between vehicular emissions and cardiorespiratory disease risk in Brazil and its variation by spatial clustering of socio-economic factors.
Topics: Air Pollutants; Brazil; Carbon Monoxide; Cardiovascular Diseases; Cluster Analysis; Environmental Mo | 2016 |
The influence of the winter North Atlantic Oscillation index on hospital admissions through diseases of the circulatory system in Lisbon, Portugal.
Topics: Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Cities; Hospitalization; Humans; Linear Mo | 2017 |
My Continuing Evolution as a Surgeon-Scientist: A Decade after the Jacobson Promising Investigator Award.
Topics: Awards and Prizes; Biomarkers; Carbon Monoxide; Cardiovascular Agents; Cardiovascular Diseases; Hist | 2017 |
Circulating carbon monoxide level is elevated after sleep in patients with obstructive sleep apnea.
Topics: Carbon Monoxide; Cardiovascular Diseases; Chromatography, Gas; Continuous Positive Airway Pressure; | 2008 |
Do current levels of air pollution kill? The impact of air pollution on population mortality in England.
Topics: Adolescent; Adult; Aged; Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Cr | 2009 |
Health risk estimation due to carbon monoxide pollution at different spatial levels in Santiago, Chile.
Topics: Aged; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Chile; Environmental Monitoring; Epid | 2010 |
Air quality and cardiovascular health: smoke and pollution matter.
Topics: Carbon Monoxide; Cardiovascular Diseases; Humans; Particulate Matter; Risk Factors; Tobacco Smoke Po | 2009 |
Emergency hospital admissions for cardiovascular diseases and ambient levels of carbon monoxide: results for 126 United States urban counties, 1999-2005.
Topics: Aged; Air Pollutants; Automobile Driving; Carbon Monoxide; Cardiovascular Diseases; Emergency Servic | 2009 |
Temperature-dependent association between mortality rate and carbon monoxide level in a subtropical city: Kaohsiung, Taiwan.
Topics: Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Cities; Environmental Exposure; Humans; Mo | 2009 |
Impact of improved air quality during the 1996 Summer Olympic Games in Atlanta on multiple cardiovascular and respiratory outcomes.
Topics: Air Pollutants; Air Pollution; Athletes; Carbon Monoxide; Cardiovascular Diseases; Emergency Service | 2010 |
Acute effects of passive smoking on blood pressure and heart rate in healthy females.
Topics: Adult; Blood Pressure; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Female; Heart Ra | 2010 |
Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community.
Topics: Adult; Carbon Monoxide; Cardiovascular Diseases; Cross-Sectional Studies; Data Collection; Exhalatio | 2010 |
Ambient air pollution and daily mortality in Anshan, China: a time-stratified case-crossover analysis.
Topics: Adolescent; Adult; Aged; Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Ch | 2010 |
Burden of disease attributable to air pollutants from municipal solid waste incinerators in Seoul, Korea: a source-specific approach for environmental burden of disease.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Cities; Demography; Environ | 2011 |
Fine particulate matter constituents associated with cardiovascular hospitalizations and mortality in New York City.
Topics: Adult; Aged; Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Hospitalizatio | 2011 |
Ambient carbon monoxide and daily mortality in three Chinese cities: the China Air Pollution and Health Effects Study (CAPES).
Topics: Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; China; Cities; Humans; Humidity; Regressio | 2011 |
Acute mortality effects of carbon monoxide in the Pearl River Delta of China.
Topics: Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; China; Cities; Environmental Exposure; Fem | 2011 |
Apparent temperature and cause-specific mortality in Copenhagen, Denmark: a case-crossover analysis.
Topics: Adult; Aged; Aged, 80 and over; Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Cause of D | 2011 |
Toxicological findings in 889 fatally injured obese pilots involved in aviation accidents.
Topics: Accidents, Aviation; Body Mass Index; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; C | 2012 |
Air pollution and autonomic and vascular dysfunction in patients with cardiovascular disease: interactions of systemic inflammation, overweight, and gender.
Topics: Aged; Air Pollutants; Air Pollution; Autonomic Nervous System Diseases; Blood Pressure Monitoring, A | 2012 |
Power estimation using simulations for air pollution time-series studies.
Topics: Air Pollutants; Air Pollution; Carbon; Carbon Monoxide; Cardiovascular Diseases; Computer Simulation | 2012 |
Effects of the Asian dust events on daily mortality in Seoul, Korea.
Topics: Age Factors; Aged; Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Dust; Humans; Korea; Li | 2002 |
Air pollution and daily mortality in a city with low levels of pollution.
Topics: Air Pollutants; Air Pollution; British Columbia; Carbon Monoxide; Carbon Monoxide Poisoning; Cardiov | 2003 |
[The mechanism of action of organic nitrates].
Topics: Biotransformation; Carbon Monoxide; Cardiovascular Diseases; Humans; Nitrates; Vasodilator Agents | 2003 |
Relationship between air pollution and daily mortality in a tropical city: Kaohsiung, Taiwan.
Topics: Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Cause of Death; Humans; Mortality; Nitrogen | 2003 |
[Health conditions of automobile drivers as reflected by autopsy findings].
Topics: Automobiles; Autopsy; Carbon Monoxide; Cardiovascular Diseases; Cardiovascular System; Humans | 1959 |
CIGARETTE SMOKING AND THE ROLE OF THE PHYSICIAN.
Topics: Bronchitis; Carbon Monoxide; Carcinogens; Cardiovascular Diseases; Emphysema; Health Education; Huma | 1964 |
Air pollution and heart rate variability among the elderly in Mexico City.
Topics: Aged; Aged, 80 and over; Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Female; Heart Rat | 2003 |
Relationship between ambient air pollution and hospital admissions for cardiovascular diseases in kaohsiung, taiwan.
Topics: Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Cross-Over Studies; Environmental Monitorin | 2004 |
Water-soluble carbon monoxide-releasing molecules: helping to elucidate the vascular activity of the 'silent killer'.
Topics: Carbon Monoxide; Cardiovascular Diseases; Cells, Cultured; Humans; Organometallic Compounds; Solubil | 2004 |
Association between particulate matter and emergency room visits, hospital admissions and mortality in Spokane, Washington.
Topics: Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Emergency Service, Hospital; Humans; Model | 2005 |
Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study.
Topics: Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Dust; Environmental Monitoring; Factor VII | 2005 |
Effects of Asian dust storm events on daily hospital admissions for cardiovascular disease in Taipei, Taiwan.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Dust; Environmental Monitor | 2005 |
Synoptic weather patterns and modification of the association between air pollution and human mortality.
Topics: Air Pollutants; Air Pollution; Canada; Carbon Monoxide; Cardiovascular Diseases; Cities; Dust; Envir | 2005 |
Endogenous carbon monoxide production correlates weakly with severity of acute illness.
Topics: APACHE; Breath Tests; Carbon Monoxide; Cardiovascular Diseases; Critical Illness; Female; Humans; In | 2006 |
The relationship between changes in daily air pollution and hospitalizations in Perth, Australia 1992-1998: a case-crossover study.
Topics: Air Pollution; Asthma; Carbon Monoxide; Cardiovascular Diseases; Cities; Cross-Sectional Studies; En | 2006 |
Air pollution and cardiovascular admissions association in Spain: results within the EMECAS project.
Topics: Aged; Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Female; Hospitalization; Humans; Mal | 2006 |
Evaluation of the effects of a novel carbon monoxide releasing molecule (CORM-3) in an in vitro model of cardiovascular inflammation. 1. Histamine in allergy, inflammation, tissue growth and repair.
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Disease Models, Animal; Endothelial Cells; Granul | 2006 |
COHb% as a marker of cardiovascular risk in never smokers: results from a population-based cohort study.
Topics: Adult; Biomarkers; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Cohort Studies; Foll | 2006 |
Ambient air pollution and cardiovascular emergency department visits in potentially sensitive groups.
Topics: Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Comorbidity; Cross-Over Studies; Diabetes C | 2007 |
Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease.
Topics: Adult; Biomarkers; C-Reactive Protein; Carbon Monoxide; Cardiovascular Diseases; Endothelial Cells; | 2007 |
Short-term effects of carbon monoxide on mortality: an analysis within the APHEA project.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Environmental Monitoring; E | 2007 |
The heart dangers of CO. Understanding cardiovascular risks to responders from CO exposure.
Topics: Carbon Monoxide; Cardiovascular Diseases; Emergency Medical Technicians; Humans; Occupational Exposu | 2007 |
Air pollution and cardiovascular health in Mandi-Gobindgarh, Punjab, India - a pilot study.
Topics: Adolescent; Adult; Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Chlorine | 2007 |
Oxygen affinity of hemoglobin in patients with cardiovascular diseases, anemia, and cirrhosis of the liver.
Topics: Anemia; Carbon Monoxide; Cardiovascular Diseases; Hemoglobins; Humans; Hydrogen-Ion Concentration; L | 1967 |
[Pathology in firemen].
Topics: Acrolein; Adult; Burns, Inhalation; Carbon Dioxide; Carbon Monoxide; Cardiovascular Diseases; Cyanid | 1983 |
Epidemiological bases for the current ambient carbon monoxide standards.
Topics: Air Pollutants; Animals; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Dogs; Electroc | 1983 |
[The environment and cardiovascular disease].
Topics: Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Environmental Pollution; Humans; Noise; Ra | 1981 |
No proof of environmental ill effects on heart.
Topics: Air Pollutants; Animals; Carbon Monoxide; Cardiovascular Diseases; Environment; Heart; Humans; Micro | 1980 |
Impact of the environment on cardiovascular disease. Report of the American Heart Association Task Force on environment and the cardiovascular system.
Topics: American Heart Association; Carbon Monoxide; Cardiovascular Diseases; Environment; Humans; Noise, Oc | 1981 |
Cardiovascular diseases among foundry workers exposed to carbon monoxide.
Topics: Carbon Monoxide; Cardiovascular Diseases; Cohort Studies; Humans; Incidence; Male; Occupational Expo | 1994 |
[Smoking in the workplace].
Topics: Carbon Monoxide; Cardiovascular Diseases; Humans; Lung Diseases, Obstructive; Lung Neoplasms; Nitro | 1994 |
Smokeless cigarettes not harmless, researchers say.
Topics: Carbon Monoxide; Cardiovascular Diseases; Humans; Neoplasms; Nicotine; Plants, Toxic; Tobacco, Smoke | 1996 |
Methylene chloride, carboxyhemoglobin and cardiac risk.
Topics: Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Dose-Response Relationship, Drug; Envir | 1997 |
Increased plasma viscosity during an air pollution episode: a link to mortality?
Topics: Adult; Air Pollutants; Air Pollution; Blood Viscosity; Carbon Monoxide; Cardiovascular Diseases; Cro | 1997 |
Air pollution and hospital admissions for cardiovascular disease in Tucson.
Topics: Aged; Air Pollution; Arizona; Carbon Monoxide; Cardiovascular Diseases; Confidence Intervals; Databa | 1997 |
Monitoring and analysis of occupational exposure to chain saw exhausts.
Topics: Adult; Air Pollutants, Occupational; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Ge | 1997 |
Mortality from cardiovascular diseases and sudden death in ferroalloy plants.
Topics: Adult; Aged; Aged, 80 and over; Alloys; Carbon Monoxide; Cardiovascular Diseases; Cause of Death; Co | 1997 |
Cardiovascular disease hospitalization and ambient levels of carbon monoxide.
Topics: Adult; Aged; Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Female; Hospitalization; Huma | 1998 |
Air pollution and daily hospital admissions in metropolitan Los Angeles.
Topics: Adult; Aged; Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Environmental | 2000 |
Air pollution and emergency hospital admissions for cardiovascular diseases in Valencia, Spain.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Emergencies; Environmental | 2001 |
Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994.
Topics: Air Pollutants; Air Pollution; Analysis of Variance; Carbon Monoxide; Cardiovascular Diseases; Human | 2000 |
[Acute effects of air pollution in Rome].
Topics: Acute Disease; Adolescent; Adult; Aged; Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascul | 2000 |
Effect of ambient level of carbon monoxide on cardiopulmonary disease.
Topics: Air Pollution; Animals; Carbon Monoxide; Cardiovascular Diseases; Haplorhini; Humans; Lung Diseases | 1978 |
Cardiovascular disease and environmental exposure.
Topics: Animals; Carbon Disulfide; Carbon Monoxide; Cardiovascular Diseases; Coronary Disease; Environmental | 1979 |
Effect of carbon monoxide on cardiovascular disease.
Topics: Air Pollution; Arteriosclerosis; Carbon Monoxide; Cardiovascular Diseases; Coronary Disease; Hemodyn | 1979 |
Model studies linking carbon monoxide and/or nicotine to arteriosclerosis and cardiovascular disease.
Topics: Animals; Arteries; Arteriosclerosis; Carbon Monoxide; Cardiovascular Diseases; Cholesterol; Heart; H | 1979 |
Evaluation of the role of carbon monoxide and nicotine in the pathogenesis of arteriosclerosis and cardiovascular disease.
Topics: Animals; Arteriosclerosis; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Humans; Nico | 1979 |
Summary of the Workshop on Carbon Monoxide and Cardiovascular Disease, Berlin, October 10--12, 1978.
Topics: Carbon Monoxide; Cardiovascular Diseases; Humans; Smoking | 1979 |
Smoking and heart disease: current thinking.
Topics: Adult; Aged; Carbon Monoxide; Cardiovascular Diseases; Cardiovascular System; Cerebrovascular Disord | 1979 |
Health effects during a smog episode in West Germany in 1985.
Topics: Acid Rain; Air Pollutants; Carbon Dioxide; Carbon Monoxide; Cardiovascular Diseases; Cross-Sectional | 1989 |
Vigorous physical activity and cardiovascular risk factors in young adults.
Topics: Adult; Blood Pressure; Body Height; Body Weight; California; Carbon Monoxide; Cardiovascular Disease | 1986 |
Concerns about passive smoking.
Topics: Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Humans; Risk; Tobacco Smoke Pollution | 1986 |
Cardiovascular status of female beagles exposed to air pollutants.
Topics: Air Pollution; Animals; Arteriosclerosis; Carbon Monoxide; Cardiovascular Diseases; Cardiovascular S | 1972 |
Smoking tables for carbon monoxide?
Topics: Carbon Monoxide; Carboxyhemoglobin; Cardiovascular Diseases; Government Publications as Topic; Healt | 1973 |
[Cardiovascular disease and smoking: implications for medical practice (author's transl)].
Topics: Angina Pectoris; Carbon Monoxide; Cardiovascular Diseases; Coronary Disease; Humans; Nicotine; Obesi | 1974 |
[Carbon monoxide concentration in the air exhaled by the healthy and the ill].
Topics: Carbon Monoxide; Cardiovascular Diseases; Diabetes Mellitus; Humans; Kidney Diseases; Respiration; S | 1972 |
[Effect of tobacco-smoking on the vascular system].
Topics: Adult; Aged; Animals; Arteriosclerosis; Blood Coagulation; Carbon Monoxide; Cardiovascular Diseases; | 1972 |
Sixty days in a submarine: the pathophysiological and metabolic cost.
Topics: Acid-Base Equilibrium; Adrenal Cortex Hormones; Air Pollution; Calcium; Carbon Dioxide; Carbon Monox | 1973 |
Carbon monoxide research--recent and remote.
Topics: Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Central Nervous System Diseases; Denmark; E | 1970 |
[Cardiovascular system in workers (physiology--pathology--prevention)].
Topics: Adolescent; Adult; Aged; Aging; Aorta; Arteries; Blood Pressure; Calcium; Carbon Monoxide; Cardiac O | 1970 |
Acceleration of spontaneous intimal--subintimal changes in rabbit aorta by a prolonged moderate carbon monoxide exposure.
Topics: Animals; Aorta; Arteriosclerosis; Carbon Monoxide; Cardiovascular Diseases; Hemoglobins; Hypoxia; Ma | 1969 |